Steroid-induced osteoporosis

PREVIEW

Many of the nearly 15 million Americans with asthma can effectively control their symptoms with bronchodilators or low-dose corticosteroids, which have few adverse effects. However, those who require more potent long-term corticosteroid therapy are at increased risk for serious complications such as osteoporosis. The authors discuss risk assessment, prevention, and treatment of bone loss in asthma patients who are given long-term, systemic corticosteroids.